| Literature DB >> 30261863 |
Alfred C Gellhorn1, Jordan M Stumph2, Hashem E Zikry3, Carly A Creelman4, Rachel Welbel4.
Abstract
BACKGROUND: Evaluation of muscle strength as performed routinely with a dynamometer may be limited by important factors such as pain during muscle contraction. Few studies have compared formal strength testing with ultrasound to measure muscle bulk in adults with knee osteoarthritis (OA).Entities:
Keywords: Osteoarthritis; Reliability; Strength; Ultrasound
Mesh:
Year: 2018 PMID: 30261863 PMCID: PMC6161398 DOI: 10.1186/s12891-018-2267-4
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1Ultrasound image of the quadriceps, measured at mid thigh. Calipers demarcate the muscle thickness, measured from the perimysium of the rectus femoris to the cortex of the femur
Subject baseline characteristics, N = 23
| Mean (SD) or percent | |
|---|---|
| Age | 63.8 (9.3) |
| Gender, female | 52% |
| Weight, kg | 77.4 (14.5) |
| BMI | 26.9 (3.7) |
| Pain level | 4.1 (1.8) |
| Symptomatic side, right | 52% |
| Symptom duration (months) | 44.8 (62.1) |
| Symptomatic KL grade | |
| 0 | 0 |
| 1 | 1 |
| 2 | 9 |
| 3 | 12 |
| 4 | 0 |
| Asymptomatic KL grade | |
| 0 | 8 |
| 1 | 7 |
| 2 | 7 |
| 3 | 0 |
| 4 | 0 |
| WOMAC pain subscale (0–20) | 4.6 (3.2) |
| WOMAC stiffness subscale (0–8) | 3.1 (1.7) |
| WOMAC function subscale (0–68) | 17.45 (13.3) |
| WOMAC total (0–96) | 25.3 (17.4) |
NRS Numeric Rating System, BMI Body Mass Index, KL Kellgren Lawrence, WOMAC Western Ontario and McMaster Arthritis Index
Subject muscle characteristics
| Paired t-test | |||
|---|---|---|---|
| Symptomatic | Asymptomatic | ||
| Strength measured as torque (Nm) normalized to body weight (kg) | |||
| Knee extensor | 96 (58.9) | 95.2 (53.6) | 0.84 |
| Hip abductors | 85.8 (27.1) | 88.5 (29.1) | 0.44 |
| Hip adductors | 90.4 (31.8) | 91.9 (34.2) | 0.72 |
| Ankle plantarflexors | 29.1 (11.1) | 30.3 (11.7) | 0.26 |
| Muscle thickness (mm) normalized to weight (kg) | |||
| Quadriceps | 0.37 (0.12) | 0.38 (0.12) | 0.32 |
| Hip abductors | 0.42 (0.13) | 0.42 (0.13) | 0.72 |
| Hip adductors | 0.59 (0.18) | 0.60 (0.18) | 0.24 |
| Ankle plantarflexors | 0.56 (0.24) | 0.56 (0.22) | 0.98 |
| Muscle thickness (mm) non-normalized | |||
| Quad | 28.4 (9.1) | 29.2 (9.3) | 0.27 |
| Hip abductors | 32.0 (10.9) | 31.7 (10.2) | 0.61 |
| Hip adductors | 44.7 (13.3) | 45.4 (12.5) | 0.34 |
| Ankle plantarflexors | 42.4 (17.5) | 42.4 (16.2) | 0.99 |
The terms in parentheses indicate standard deviations
Unadjusted Spearman’s rho correlations between muscle measures and functional measures
| Muscle group | WOMAC pain | WOMAC stiffness | WOMAC function | WOMAC total | Age | Gender | BMI | Symptom duration |
|---|---|---|---|---|---|---|---|---|
| Muscle strength measures | ||||||||
| Symptomatic knee extension | −0.42 | − 0.18 | − 0.35 | − 0.36 | − 0.10 |
| 0.18 | 0.21 |
| Asymptomatic knee extension | − 0.31 | − 0.17 | − 0.29 | − 0.27 | − 0.02 | 0.41 | − 0.20 | 0.20 |
| Symptomatic hip abduction |
| − 0.22 |
|
| − 0.25 | 0.17 | 0.01 | 0.11 |
| Asymptomatic hip abduction |
| − 0.28 | − |
| − 0.22 |
| 0.04 | 0.10 |
| Symptomatic hip adduction |
| −0.13 |
|
| 0.02 | 0.36 | −0.09 | 0.07 |
| Asymptomatic hip adduction |
| −0.25 |
| 0.10 | 0.28 | −0.07 | −0.08 | |
| Symptomatic ankle plantarflexion |
| −0.06 |
|
|
| 0.30 | − 0.09 | 0.19 |
| Asymptomatic ankle plantarflexion |
| −0.18 |
|
| −0.35 | 0.25 | −0.04 | 0.27 |
| Muscle thickness measures | ||||||||
| Symptomatic quadriceps thickness |
| −0.09 |
|
| − 0.35 | 0.37 | − 0.04 | 0.15 |
| Asymptomatic quadriceps thickness | −0.38 | −0.22 |
|
| − 0.29 |
| − 0.01 | 0.15 |
| Symptomatic hip abductor thickness | −0.13 | −0.09 | − 0.14 | −0.14 | 0.05 |
| 0.03 | −0.10 |
| Asymptomatic hip abductor thickness | −0.20 | − 0.02 | − 0.25 | − 0.22 | − 0.05 |
| 0.08 | −0.10 |
| Symptomatic hip adductor thickness |
| − 0.11 |
|
| − 0.02 |
| − 0.30 | − 0.06 |
| Asymptomatic hip adductor thickness |
| − 0.10 | − 0.40 | −0.38 | − 0.04 |
| − 0.27 | − 0.11 |
| Symptomatic calf thickness | − 0.39 | − 0.04 | − 0.39 | −0.37 | − 0.14 |
| − 0.12 | −0.05 |
| Asymptomatic calf thickness | −0.37 | −0.03 | − 0.37 | −0.35 | − 0.15 |
| − 0.14 | −0.08 |
WOMAC Western Ontario and McMaster Arthritis Index, BMI Body Mass Index
Strength measured in torque (Nm) normalized to body weight (kg), ie Nm/kg
Values indicated by * with bold text indicates significance at 0.05 level, ‡ with bold text indicates significance at 0.01 level
Summary of multivariable regression analysis for muscle characteristics predicting the total WOMAC score, controlled for gender
| Predictor | Unadjusted beta | |
|---|---|---|
| Muscle thickness measures (mm/kg) | ||
| Symptomatic quadriceps | −67.2 | 0.009 * |
| Asymptomatic quadriceps | −60.5 | 0.031 * |
| Symptomatic hip abductors | − 11 | 0.66 |
| Asymptomatic hip abductors | −21.7 | 0.85 |
| Sympatomatic hip adductors | −27.8 | 0.13 |
| Asympatomatic hip adductors | −29 | 11 |
| Symptomatic calf | −20.6 | 0.14 |
| Asymptomatic calf | −19.9 | 0.19 |
| Muscle torque measures (Nm/kg) | ||
| Symptomatic knee extensors | −0.036 | 0.57 |
| Asymptomatic knee extensors | −0.051 | 0.12 |
| Symptomatic hip abductors | −0.197 | 0.08 |
| Asymptomatic hip abductors | −0.138 | 0.27 |
| Symptomatic hip adductors | −0.126 | 0.26 |
| Asymptomatic hip addutors | −0.188 | 0.06 |
| Symptomatic ankle plantarflexors | −0.65 | 0.05 |
| Asymptomatic ankle plantarflexors | −0.56 | 0.05 |
* indicates p < 0.05